Trademark: 97635360
Word
CTX130
Status Date
Tuesday, April 23, 2024
Filing Date
Monday, October 17, 2022
Published for Opposition
Tuesday, February 27, 2024
5 Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of hematologic malignancies; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of hematologic malignancies; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of hematologic malignancies
Oct 20, 2022
New Application Entered
Oct 20, 2022
New Application Office Supplied Data Entered
Mar 31, 2023
Assigned To Examiner
May 9, 2023
Non-Final Action Written
May 9, 2023
Non-Final Action E-Mailed
May 9, 2023
Notification Of Non-Final Action E-Mailed
Aug 9, 2023
Teas Response To Office Action Received
Aug 9, 2023
Correspondence Received In Law Office
Aug 10, 2023
Teas/Email Correspondence Entered
Sep 19, 2023
Assigned To Examiner
Oct 2, 2023
Final Refusal Written
Oct 2, 2023
Final Refusal E-Mailed
Oct 2, 2023
Notification Of Final Refusal Emailed
Dec 22, 2023
Application Extension To Response Period - Received
Dec 22, 2023
Application Extension Granted/Receipt Provided
Dec 22, 2023
Teas Request For Reconsideration Received
Dec 22, 2023
Correspondence Received In Law Office
Dec 22, 2023
Teas/Email Correspondence Entered
Feb 27, 2024
Published For Opposition
Apr 23, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 23, 2024
Approved For Pub - Principal Register
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
